Biosensia - cutting edge point of care in vitro diagnostics

- nanocomms.com

Biosensia Ltd is developing the innovative point of care in vitro diagnostics platform RapiPlex

Not Applicable $ 8.95


New Page 1

- panprobebiotech.com

description

Not Applicable $ 8.95